These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 11313174

  • 1. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).
    Flamen P, Hoekstra OS, Homans F, Van Cutsem E, Maes A, Stroobants S, Peeters M, Penninckx F, Filez L, Bleichrodt RP, Mortelmans L.
    Eur J Cancer; 2001 May; 37(7):862-9. PubMed ID: 11313174
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY, Liang JA, Chen YK, Tsai CY, Kao CH.
    Hepatogastroenterology; 2006 May; 53(69):348-50. PubMed ID: 16795969
    [Abstract] [Full Text] [Related]

  • 3. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.
    Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA.
    Ann Surg; 1998 Mar; 227(3):319-23. PubMed ID: 9527052
    [Abstract] [Full Text] [Related]

  • 4. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
    Vallam KC, Guruchannabasavaiah B, Agrawal A, Rangarajan V, Ostwal V, Engineer R, Saklani A.
    Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
    [Abstract] [Full Text] [Related]

  • 5. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E, Soydal C, Araz M, Kir KM, Ibis E.
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [Abstract] [Full Text] [Related]

  • 6. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
    Khan K, Athauda A, Aitken K, Cunningham D, Watkins D, Starling N, Cook GJ, Kalaitzaki E, Chau I, Rao S.
    Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of fluoro-2-deoxyglucose positron emission tomography for investigating unexplained rising carcinoembryonic antigen levels that occur during the postoperative surveillance of lung cancer patients.
    Isobe K, Hata Y, Takai Y, Shibuya K, Takagi K, Homma S.
    Int J Clin Oncol; 2009 Dec; 14(6):497-501. PubMed ID: 19967484
    [Abstract] [Full Text] [Related]

  • 8. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
    Ozkan E, Soydal C, Araz M, Aras G.
    Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225
    [Abstract] [Full Text] [Related]

  • 9. Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.
    Liong SY, Kochhar R, Renehan AG, Manoharan P.
    ANZ J Surg; 2012 Oct; 82(10):729-36. PubMed ID: 22989147
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
    Gade M, Kubik M, Fisker RV, Thorlacius-Ussing O, Petersen LJ.
    Cancer Imaging; 2015 Aug 13; 15(1):11. PubMed ID: 26263901
    [Abstract] [Full Text] [Related]

  • 11. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
    Liu FY, Chen JS, Changchien CR, Yeh CY, Liu SH, Ho KC, Yen TC.
    Dis Colon Rectum; 2005 Oct 13; 48(10):1900-12. PubMed ID: 15991059
    [Abstract] [Full Text] [Related]

  • 12. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
    Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, Has D, Isik G, Asoglu O, Kapran Y, Adalet I.
    Ann Nucl Med; 2012 Aug 13; 26(7):551-8. PubMed ID: 22644560
    [Abstract] [Full Text] [Related]

  • 13. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
    Metser U, You J, McSweeney S, Freeman M, Hendler A.
    AJR Am J Roentgenol; 2010 Mar 13; 194(3):766-71. PubMed ID: 20173157
    [Abstract] [Full Text] [Related]

  • 14. DIAGNOSTIC ROLE OF FLUORINE-18 (18F) FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY IN DETECTING RECURRENT DISEASE IN PATIENTS WITH COLORECTAL CANCER AND ELEVATED CARCINOEMBRYONIC ANTIGEN.
    Matovina E, Mihailović J, Nikoletić K, Srbovan D.
    Med Pregl; 2015 Mar 13; 68(11-12):376-81. PubMed ID: 26939303
    [Abstract] [Full Text] [Related]

  • 15. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
    Hung GU, Shiau YC, Tsai SC, Chao TH, Ho YJ, Kao CH.
    Anticancer Res; 2001 Mar 13; 21(2B):1375-8. PubMed ID: 11396217
    [Abstract] [Full Text] [Related]

  • 16. [¹⁸F-FDG PET/CT. Its correlation with carcinoembryonic antigen in patients with colorectal carcinoma].
    Granados Rangel O, Estrada G, Altamirano J.
    Gac Med Mex; 2014 Mar 13; 150(6):509-17. PubMed ID: 25375281
    [Abstract] [Full Text] [Related]

  • 17. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S, Stojiljkovic M, Sobic-Saranovic D, Pandurevic S, Brajkovic L, Milosevic I, Grozdic-Milojevic I, Artiko V.
    Neoplasma; 2017 Mar 13; 64(6):954-961. PubMed ID: 28895416
    [Abstract] [Full Text] [Related]

  • 18. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
    Chen SW, Chen YK.
    World J Surg Oncol; 2017 Dec 29; 15(1):230. PubMed ID: 29284496
    [Abstract] [Full Text] [Related]

  • 19. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
    Lee JH, Park SG, Jee KN, Park DG, Namgung H, Song IH.
    Nucl Med Commun; 2010 Jun 29; 31(6):576-82. PubMed ID: 20216474
    [Abstract] [Full Text] [Related]

  • 20. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
    Kyoto Y, Momose M, Kondo C, Itabashi M, Kameoka S, Kusakabe K.
    Ann Nucl Med; 2010 Jun 29; 24(5):395-401. PubMed ID: 20364373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.